An Open-Label Phase 4 Study of Carfilzomib Plus Dexamethsone to Assess Tolerability and Adherence in Subjects with Relapsed or Refractory Multiple Myeloma at US Oncology Centers

Type of Cancer

Phase

Division (Location)

Study ID

NCT#

Brief Description
An Open-Label Phase 4 Study of Carfilzomib Plus Dexamethsone to Assess Tolerability and Adherence in Subjects with Relapsed or Refractory Multiple Myeloma at US Oncology Centers

To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.